Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Sees Significant Decrease in Short Interest

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) saw a significant decrease in short interest in the month of August. As of August 14th, there was short interest totaling 3,083 shares, a decrease of 70.3% from the July 30th total of 10,365 shares. Based on an average daily trading volume, of 41,171 shares, the short-interest ratio is currently 0.1 days.

Alpha Tau Medical Stock Performance

DRTSW stock traded down $0.05 during trading on Thursday, hitting $4.05. The company had a trading volume of 31,864 shares, compared to its average volume of 62,327. The business has a 50-day moving average of $3.23 and a 200-day moving average of $2.04. Alpha Tau Medical has a one year low of $0.20 and a one year high of $4.28.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.